PT PALVELLA THERAPEUTICS, INC. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the PALVELLA THERAPEUTICS, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was filed on 4 September 2026 (Levée d'options). Among the most active insiders: Goin Kathleen. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate PALVELLA THERAPEUTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 September 2026
All Executives36 Thresholds0 Prospectus0 Other0
Declarations 36 total
◇ Director · Executives · 2 Sept 2026
313 shares @ US$127.20 Common Stock SEC:0001104659-26-105494:0
▼ Director · Executives · 2 Sept 2026
313 shares @ US$157.00 Common Stock SEC:0001104659-26-105494:1
▼ Chief Operating Officer · Executives · 19 Aug 2026
1,998 shares @ US$151.7979 0.013% mcap 8.0% of flow Common Stock SEC:0001104659-26-099222:3
◇ Chief Operating Officer · Executives · 19 Aug 2026
2,154 shares @ US$7.14 0.0007% mcap 0.4% of flow Common Stock SEC:0001104659-26-099222:0
◇ Chief Operating Officer · Executives · 19 Aug 2026
2,148 shares @ US$9.08 0.0008% mcap 0.5% of flow Common Stock SEC:0001104659-26-099222:1
▼ Chief Operating Officer · Executives · 19 Aug 2026
1,500 shares @ US$151.39 0.0098% mcap 6.0% of flow Common Stock SEC:0001104659-26-099222:2
▼ Chief Operating Officer · Executives · 19 Aug 2026
400 shares @ US$152.9975 0.0026% mcap 1.6% of flow Common Stock SEC:0001104659-26-099222:4
▼ Chief Operating Officer · Executives · 19 Aug 2026
102 shares @ US$155.5898 0.0007% mcap 0.4% of flow Common Stock SEC:0001104659-26-099222:5
▼ Chief Operating Officer · Executives · 19 Aug 2026
302 shares @ US$156.77 0.0020% mcap 1.2% of flow Common Stock SEC:0001104659-26-099222:6
● Officer · Executives · 19 Aug 2026
4,302 shares @ US$150.42 0.028% mcap 20.8% of flow Common Stock SEC144:0001967940-26-000044
▼ Chief Operating Officer · Executives · 15 Jul 2026
840 shares @ US$148.4018 0.0065% mcap 5.1% of flow Common Stock SEC:0001104659-26-084620:3
◇ Chief Operating Officer · Executives · 15 Jul 2026
2,154 shares @ US$7.14 0.0008% mcap 0.6% of flow Common Stock SEC:0001104659-26-084620:0
◇ Chief Operating Officer · Executives · 15 Jul 2026
2,148 shares @ US$9.08 0.0010% mcap 0.8% of flow Common Stock SEC:0001104659-26-084620:1
▼ Chief Operating Officer · Executives · 15 Jul 2026
522 shares @ US$147.1365 0.0040% mcap 3.2% of flow Common Stock SEC:0001104659-26-084620:2
▼ Chief Operating Officer · Executives · 15 Jul 2026
1,029 shares @ US$149.2667 0.0080% mcap 6.3% of flow Common Stock SEC:0001104659-26-084620:4
▼ Chief Operating Officer · Executives · 15 Jul 2026
1,911 shares @ US$150.2529 0.015% mcap 11.8% of flow Common Stock SEC:0001104659-26-084620:5
● Officer · Executives · 15 Jul 2026
4,302 shares @ US$149.68 0.034% mcap 36.7% of flow Common Stock SEC144:0001967940-26-000039
● Officer · Executives · 17 Jun 2026
4,302 shares @ US$110.7329 0.024% mcap 42.6% of flow Common Stock SEC144:0001967940-26-000032
▼ Chief Operating Officer · Executives · 15 Apr 2026
1,500 shares @ US$127.1254 0.0096% mcap 32.7% of flow Common Stock SEC:0001104659-26-044895:3
▼ Chief Operating Officer · Executives · 15 Apr 2026
561 shares @ US$128.2349 0.0036% mcap 12.4% of flow Common Stock SEC:0001104659-26-044895:4
▼ Chief Operating Officer · Executives · 15 Apr 2026
639 shares @ US$129.1692 0.0042% mcap 14.2% of flow Common Stock SEC:0001104659-26-044895:5
▼ Chief Operating Officer · Executives · 15 Apr 2026
100 shares @ US$130.33 0.0007% mcap 2.2% of flow Common Stock SEC:0001104659-26-044895:6
◇ Chief Operating Officer · Executives · 15 Apr 2026
2,154 shares @ US$7.14 0.0008% mcap 2.6% of flow Common Stock SEC:0001104659-26-044895:0
◇ Chief Operating Officer · Executives · 15 Apr 2026
2,148 shares @ US$9.08 0.0010% mcap 3.3% of flow Common Stock SEC:0001104659-26-044895:1
▼ Chief Operating Officer · Executives · 15 Apr 2026
1,502 shares @ US$125.9647 0.0096% mcap 32.5% of flow Common Stock SEC:0001104659-26-044895:2
25 of 36 declarations
Load more (11 remaining) 关于 PALVELLA THERAPEUTICS, INC. PALVELLA THERAPEUTICS, INC. 是一家专注于开发自身免疫疾病治疗方法的公司。该公司在纳斯达克上市，股票代码为 XNAS。